Cargando…

Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis are highly debilitating. IBDs are associated with the imbalance of inflammatory mediators within the inflamed bowel. Conventional drugs for IBD treatment include anti-inflammatory medications and immune suppressants. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fengqian, Liu, Qi, Xiong, Yang, Xu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236271/ https://www.ncbi.nlm.nih.gov/pubmed/34188471 http://dx.doi.org/10.2147/IJN.S310952

Ejemplares similares

Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease
por: Li, De-feng, et al.
Publicado: (2022)

Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials
por: Xu, Manman, et al.
Publicado: (2023)

Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease
por: Khare, Tripti, et al.
Publicado: (2020)

A Current Perspective on the Potential of Nanomedicine for Anti-Tuberculosis Therapy
por: Borah Slater, Khushboo, et al.
Publicado: (2023)

Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease
por: Shinn, Jongyoon, et al.
Publicado: (2022)

Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery route
por: Chen, Fengqian, et al.
Publicado: (2022)

Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects
por: Chopra, Hitesh, et al.
Publicado: (2022)

Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases
por: Patel, Sravan Kumar, et al.
Publicado: (2015)

Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy
por: Jacob, Eden Mariam, et al.
Publicado: (2020)

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies
por: Yang, Fan, et al.
Publicado: (2023)

Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
por: Lamprecht, Georg, et al.
Publicado: (2015)

Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
por: Neurath, Markus F., et al.
Publicado: (2015)

Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives
por: Manners, Natasha, et al.
Publicado: (2022)

Strategies for engineering advanced nanomedicines for gas therapy of cancer
por: Wang, Yingshuai, et al.
Publicado: (2020)

The potential of nanomedicine therapies to treat neovascular disease in the retina
por: Farjo, Krysten M, et al.
Publicado: (2010)

Anti-inflammatory Nanomedicine for Cardiovascular Disease
por: Katsuki, Shunsuke, et al.
Publicado: (2017)

Advanced nanomedicines for the treatment of inflammatory diseases
por: Brusini, Romain, et al.
Publicado: (2020)

High drug-loading nanomedicines: progress, current status, and prospects
por: Shen, Shihong, et al.
Publicado: (2017)

Nanomedicine-based commercial formulations: current developments and future prospects
por: Thapa, Raj Kumar, et al.
Publicado: (2022)

Nanomedicine and therapy of lung diseases
por: Garcia, Fabrício de Melo
Publicado: (2014)

Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence
por: Misra, Sanghamitra M.
Publicado: (2014)

Nanomedicine potentiates mild photothermal therapy for tumor ablation
por: Jiang, Zijun, et al.
Publicado: (2021)

Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy
por: Liu, Chunkang, et al.
Publicado: (2022)

Advances in nanomedicines for lymphatic imaging and therapy
por: He, Pan, et al.
Publicado: (2023)

Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies
por: Bretto, Elisabetta, et al.
Publicado: (2023)

Current status of nanomedicine and nanosurgery
por: Singh, Sanjeev, et al.
Publicado: (2013)

Current research trends of nanomedicines
por: Liu, Qiuyue, et al.
Publicado: (2023)

Nanomedicine as a strategy to fight thrombotic diseases
por: Varna, Mariana, et al.
Publicado: (2015)

Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
por: Alshehri, Dikhnah, et al.
Publicado: (2021)

Nanomedicine strategies to target coronavirus
por: Heinrich, Marcel Alexander, et al.
Publicado: (2020)

The Long and the Short of Current Nanomedicines for Treating Alzheimer's Disease
por: Gong, Baofeng, et al.
Publicado: (2023)

Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease
por: Shi, Meng-Yue, et al.
Publicado: (2022)

Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design
por: Qiao, Qi, et al.
Publicado: (2021)

Identification and Validation of Signature Genes and Potential Therapy Targets of Inflammatory Bowel Disease and Periodontitis
por: Xiong, Zhe, et al.
Publicado: (2023)

Smart Materials Meet Multifunctional Biomedical Devices: Current and Prospective Implications for Nanomedicine
por: Genchi, Giada Graziana, et al.
Publicado: (2017)

Potential of Cellular Therapy for ALS: Current Strategies and Future Prospects
por: Lin, Ting-Jung, et al.
Publicado: (2022)

Present scenarios and future prospects of herbal nanomedicine for antifungal therapy
por: Yadav, Rahul, et al.
Publicado: (2022)

Hyaluronic Acid Nanoparticles as Nanomedicine for Treatment of Inflammatory Diseases
por: Rao, N.Vijayakameswara, et al.
Publicado: (2020)

Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy
por: Mishra, Rangnath, et al.
Publicado: (2020)

The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease
por: Alghoul, Zahra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_en2lbhejerh9eedgsg8asfh60f